focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Strategic Investment

18 Mar 2011 15:30

RNS Number : 2482D
China Private Equity Inv Hldgs Ld
18 March 2011
 



18 March 2011

 

China Private Equity Investments Holdings Limited

("CPE" or the "Company")

 

The Company's principal activity is to invest in unlisted companies in the telecommunications, media, and technology (TMT) and financial services sectors

 

Strategic investment in leading online financial services company

 

The Board of CPE (AIM: CPEH) is pleased to announce that the Company has entered into an Agreement with Furuya Consultants Limited ("FCL") to acquire a 30% interest in Hong Kong-based Enfinium International Holdings Limited ("Enfinium"), a leading online financial services business, for a total consideration of US$6 million. CPE will pay for the acquisition by way of issuing 10 million new CPE Ordinary shares of no par value to FCL at a price of US$ 0.60 per share. The acquisition is conditional on approval by CPE shareholders at an EGM to be convened shortly to amend the Company's investing policy.

 

The issue of the 10 million new shares in consideration of the Agreement will give FCL 13.6% of the total issued share capital of 73,784,645 shares. In addition, under the terms of the agreement, CPE will issue an additional 2 million shares to FCL if Enfinium achieves a net audited post-tax profit of US$ 3.5 million or more for the year ending 31st December 2011.

 

The Agreement also gives CPE a seat on the Board of Enfinium, which will be taken up by CPE Chief Executive Officer Duncan Chui.

 

The acquisition is a strategic investment intended simultaneously to broaden CPE's exposure to online opportunities and provide direct access to Enfinium's global network of private equity investors. Established in 2007, Enfinium is 100%-owned by FCL. It provides its clients with a global online trading platform that allows them to trade stocks on most of the world's stock exchanges, along with forex, futures and other transactions. It has a wide network of High Net Worth investors who are seeking access to Chinese investment opportunities such as those sourced by CPE. For the twelve months ending 28 February 2011, Enfinium generated pre-tax profits of approximately US$2.5 million. As at 28 February 2011 the business had unaudited net assets of approximately US$3.5 million.

 

The new shares will be issued following shareholders' approval of the change to the Company's investing policy and are expected to be admitted for trading on the AIM market shortly afterwards. An EGM will be held in Hong Kong on a date to be announced shortly.

 

CPE Chief Executive Duncan Chui commented: "Following our announcement last November of a US$2 million strategic investment in China iEducation Group, this new Agreement marks a further important step forward for CPE, in line with our objectives of providing shareholders with an attractive return on their investment through capital appreciation.

 

"Based in Hong Kong, Enfinium taps into a wide global network of investors, many of whom have expressed serious interest in new China opportunities such as those sourced by CPE. In turn, we anticipate that CPE's public fundraising capabilities will assist Enfinium to extend its own expansion into a Chinese financial services market still undergoing rapid development against a backdrop of target GDP growth for 2011 of 7%."

 

CPE's currently-stated investment strategy is to provide shareholders with an attractive return on their investment through capital appreciation, by investing in businesses in China which the Directors believe are likely to achieve a trade sale or an IPO, predominantly within a medium to long term time horizon. A Hong Kong IPO is planned in the near future for CPE's significant investee company, Fortel Technology Holdings Limited, a digital media and technology services company operating primarily in China and in which the Company holds a 37% stake.

 

To broaden the investment opportunities further, the planned EGM will seek shareholder approval for amendments to the Company's investing policy to allow stake-holdings in businesses operating solely in China, operating in other countries as well as China but with significant exposure to the Chinese market, or operating outside China but positioned to leverage off CPE's experience to enter the Chinese market.

 

In addition to providing online trading platforms, Enfinium also offers a Corporate Advisory specialist consulting practice to help client investors pre-empt legislative, political and regulatory risks that can have material impacts on the success of transactions.

 

 

For further information, please visit www.cpe-invest.com or contact:

 

China Private Equity Investments Holdings Limited

+852 2801 6770

Duncan Chui / Ernest Wong

Shore Capital and Corporate Limited (Nominated Adviser)

+44 (0)20 7408 4090

Stephane Auton

Tavistock / First City Public Relations

Allan Piper

+852 2854 2666

Simon Hudson / Lydia Eades

+44 (0) 20 7920 3150

 

-ends-

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEASDPFEKFEFF
Date   Source Headline
24th Oct 201810:24 amRNSNet Asset Value Update
16th Oct 201810:34 amRNSDirector/PDMR Shareholding
13th Sep 20187:00 amRNSInterim Results for Six Months Ended 30 June 2018
17th Aug 201811:43 amRNSResult of AGM
13th Aug 201810:50 amRNSNet Asset Value Update
26th Jul 201812:06 pmRNSNet Asset Value Update
23rd Jul 20189:44 amRNSDisposal of Interest in Global Pharm
11th Jul 201810:38 amRNSResult of General Meeting
28th Jun 20183:50 pmRNSPosting of Annual Report and Accounts
21st Jun 20187:00 amRNSFinal Results for the Year Ended 31 December 2017
21st Jun 20187:00 amRNSAppointment of Broker
15th Jun 20188:36 amRNSDisposal of Interest in Global Pharm & GM Notice
27th Apr 20187:00 amRNSUpdate on Disposal of Interest in Global Pharm
26th Apr 20181:57 pmRNSResult of General Meeting
20th Apr 20188:49 amRNSDirector/PDMR Shareholding
5th Apr 20183:54 pmRNSDisposal and Notice of General Meeting
29th Mar 20187:00 amRNSUpdate on Disposal of Interest in Global Pharm
26th Mar 20184:44 pmRNSIncreased Ownership in HKMH
19th Mar 20187:00 amRNSNew Investment
8th Feb 201812:17 pmRNSUpdate - Net Asset Value
2nd Feb 20188:24 amRNSDirector/PDMR Shareholding
15th Jan 20187:00 amRNSFurther re. Disposal of Interest in Global Pharm
21st Dec 20178:54 amRNSIncrease in Shareholding in Hong Kong Mining
31st Oct 201710:23 amRNSNet Asset Value Update
2nd Oct 20177:00 amRNSAppointment of Director
22nd Sep 20177:00 amRNSInterim Results For Six Months End 30 June 2017
20th Sep 201711:18 amRNSAGM and Share Consolidation
15th Sep 20177:00 amRNSDisposal of Interest in Global Pharm
30th Aug 20174:50 pmRNSProposed Share Consolidation
4th Aug 20173:36 pmRNSUpdate on Global Pharm Convertible Bond
27th Jul 20177:00 amRNSNet Asset Value(s)
20th Jul 20179:43 amRNSDirectorate Change
20th Jul 20179:27 amRNSAnnual General Meeting
3rd Jul 20179:14 amRNSAppointment of Director
29th Jun 201710:45 amRNSFinal Results
22nd Jun 20178:46 amRNSFurther Payment of Proceeds for TTS Disposal
15th Jun 20179:43 amRNSPayment of Proceeds for TTS Project Disposal
25th May 201711:06 amRNSResult of Meeting
2nd May 20177:00 amRNSChange of Investment Manager and Investing Policy
24th Feb 201711:45 amRNSUPDATE ON TTS PROJECT DISPOSAL
8th Feb 20179:26 amRNSUPDATE ON TTS PROJECT DISPOSAL
31st Jan 20177:00 amRNSDistribution from GCCF
23rd Jan 20179:15 amRNSUPDATE: REDEMPTION OF GLOBAL PHARM CONVERTIBLE
13th Jan 20178:15 amRNSUPDATE ON TTS PROJECT DISPOSAL
4th Jan 20179:00 amRNSProposed Disposal
29th Dec 20167:00 amRNSDirector/PDMR Shareholding
22nd Dec 20161:18 pmRNSDirector/PDMR Shareholding
20th Dec 20164:19 pmRNSDirector/PDMR Shareholding
13th Dec 20169:23 amRNSDirector/PDMR Shareholding
6th Dec 201612:34 pmRNSCorrection to Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.